000120101 001__ 120101
000120101 005__ 20240319081022.0
000120101 0247_ $$2doi$$a10.3390/tropicalmed7090226
000120101 0248_ $$2sideral$$a129788
000120101 037__ $$aART-2022-129788
000120101 041__ $$aeng
000120101 100__ $$0(orcid)0000-0002-3485-0682$$aMatovelle, Cristina$$uUniversidad de Zaragoza
000120101 245__ $$aPrevalence and Associated Factors of Blastocystis sp. Infection in Patients with Gastrointestinal Symptoms in Spain: A Case-Control Study
000120101 260__ $$c2022
000120101 5060_ $$aAccess copy available to the general public$$fUnrestricted
000120101 5203_ $$aBlastocystis sp. is known to be the most prevalent parasite in fecal samples of humans worldwide. In the present report, a case–control study (1:9.89 (≈10)) was performed, by analyzing data from 3682 patients who attended a public hospital in the northern area of Spain showing gastrointestinal symptoms. Diagnosis was performed in human fecal samples by means of optical microscopy. The prevalence of Blastocystis sp. in patients with gastrointestinal symptoms was 9.18% (338/3682). Most of the Blastocystis sp.-infected patients tested negative for protozoa and helminths, and were underweight and foreign-born (26.4%), mainly from Africa and Central/South America. Gastrointestinal symptoms, such as abdominal pain, anorexia, halitosis, plus relative eosinophilia, as well as co-infections with pathogenic bacteria were associated with Blastocystis sp. infection. Both type 2 diabetes and treatment with immunosuppressive medicines at the time of Blastocystis sp. detection were associated with a higher proportion of infected patients. This is the first case–control study of Blastocystis sp. in humans in northern Spain and may contribute to surveillance and intervention strategies by public health authorities.
000120101 536__ $$9info:eu-repo/grantAgreement/ES/DGA/A16-20R
000120101 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000120101 590__ $$a2.9$$b2022
000120101 592__ $$a0.825$$b2022
000120101 591__ $$aPARASITOLOGY$$b12 / 37 = 0.324$$c2022$$dQ2$$eT1
000120101 593__ $$aImmunology and Microbiology (miscellaneous)$$c2022$$dQ2
000120101 591__ $$aTROPICAL MEDICINE$$b9 / 24 = 0.375$$c2022$$dQ2$$eT2
000120101 593__ $$aPublic Health, Environmental and Occupational Health$$c2022$$dQ2
000120101 591__ $$aINFECTIOUS DISEASES$$b67 / 96 = 0.698$$c2022$$dQ3$$eT3
000120101 593__ $$aInfectious Diseases$$c2022$$dQ2
000120101 594__ $$a4.1$$b2022
000120101 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000120101 700__ $$0(orcid)0000-0001-5026-5144$$aTejedor, María Teresa$$uUniversidad de Zaragoza
000120101 700__ $$0(orcid)0000-0003-0210-2919$$aMonteagudo, Luis Vicente$$uUniversidad de Zaragoza
000120101 700__ $$0(orcid)0000-0002-3764-0189$$aBeltrán, Antonio$$uUniversidad de Zaragoza
000120101 700__ $$0(orcid)0000-0001-7831-2483$$aQuílez, Joaquín$$uUniversidad de Zaragoza
000120101 7102_ $$11011$$2660$$aUniversidad de Zaragoza$$bDpto. Microb.Ped.Radio.Sal.Pú.$$cÁrea Parasitología
000120101 7102_ $$11001$$2420$$aUniversidad de Zaragoza$$bDpto. Anatom.,Embri.Genét.Ani.$$cÁrea Genética
000120101 7102_ $$11009$$2773$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Sanidad Animal
000120101 7102_ $$12008$$2780$$aUniversidad de Zaragoza$$bDpto. Produc.Animal Cienc.Ali.$$cÁrea Tecnología de Alimentos
000120101 773__ $$g7, 9 (2022), 226$$tTROPICAL MEDICINE AND INFECTIOUS DISEASE$$x2414-6366
000120101 8564_ $$s837415$$uhttps://zaguan.unizar.es/record/120101/files/texto_completo.pdf$$yVersión publicada
000120101 8564_ $$s2748076$$uhttps://zaguan.unizar.es/record/120101/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000120101 909CO $$ooai:zaguan.unizar.es:120101$$particulos$$pdriver
000120101 951__ $$a2024-03-18-16:17:15
000120101 980__ $$aARTICLE